Analyses focused on those with COVID-19 requiring critical care or dying. Data were linked to the national diabetes register, hospitalisation and critical care unit (CCU) databases. Seven controls matched for age, sex and general practice were selected per case. Methods: We identified as cases all those in Scotland with a positive SARS-CoV-2 nucleic acid test in the national laboratory database and anyone else with a death certificate mentioning COVID-19. Independent Scottish Diabetes Research Network Epidemiology Groupīackground: The risks of, and risk factors for, COVID-19 disease associated with diabetes are poorly quantified. Health Protection Scotland Public Health Scotland COVID-19 Health Protection Study Group Health Protection Scotland (Public Health Scotland) Helen M Colhoun Health Protection Scotland (Public Health Scotland) Paul M McKeigue Health Protection Scotland (Public Health Scotland) David Goldberg Public Health Scotland Alison Smith-Palmer School of Health and Life Sciences, Glasgow Caledonian University Jim McMenamin Institute of Cardiovascular and Medical Sciences, University of Glasgow Ashirwad Philip Samuel University of Glasgow - Institute of Cardiovascular and Medical Sciences John McKnight Institute of Cardiovascular and Medical Sciences, University of Glasgow Ewan Pearsonĭivision of Molecular and Clinical Medicine, University of Dundee Naveed Sattar Queen Elizabeth University Hospital Rory McCrimmonĭivision of Molecular and Clinical Medicine, University of Dundee Robert Lindsay Institute of Cardiovascular and Medical Sciences, University of Glasgow Brian Kennon Institute of Health and Wellbeing, University of Glasgow John Petrie Health Protection Scotland (Public Health Scotland) Elaine Butterly University of Edinburgh - Asthma UK Centre for Applied Research Janet Murray University of Strathclyde - Department of Mathematics & Statistics Nazir I. Institute of Genetics and Molecular Medicine, College of Medicine and Veterinary Medicine, University of Edinburgh Chris Robertson Institute of Genetics and Molecular Medicine, College of Medicine and Veterinary Medicine, University of Edinburgh Marco Colombo Institute of Genetics and Molecular Medicine, College of Medicine and Veterinary Medicine, University of Edinburgh Andreas Höhn University of Edinburgh - Usher Institute of Population Health Sciences and Informatics Sara Hatam Institute of Genetics and Molecular Medicine, College of Medicine and Veterinary Medicine, University of Edinburgh Sarah Wild Nstitute of Genetics and Molecular Medicine, College of Medicine and Veterinary Medicine, University of Edinburgh Joseph E O’Reilly Usher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh Anita Jeyam Institute of Genetics and Molecular Medicine, College of Medicine and Veterinary Medicine, University of Edinburgh Joseph Mellor School of Health and Life Sciences, Glasgow Caledonian University Thomas M Caparrotta Institute of Genetics and Molecular Medicine, College of Medicine and Veterinary Medicine, University of Edinburgh Sharon Hutchinson Health Protection Scotland (Public Health Scotland) Luke AK Blackbourn Health Protection Scotland (Public Health Scotland) Sharon Kennedy See all articles by Stuart J McGurnaghan Stuart J McGurnaghanĮalth Protection Scotland (Public Health Scotland) Amanda WeirĮalth Protection Scotland (Public Health Scotland) Jen Bishop For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact COVID-19 Disease in People with Diabetes in Scotland: Incidence, Severity and Risk Stratification Using Matched Case-Control and Prospective Cohort Studies The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. These preprints are early stage research papers that have not been peer-reviewed. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |